ASND logo

Ascendis Pharma A/S (ASND)

Profile

Full Name

Ascendis Pharma A/S

Ticker Symbol

ASND

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Denmark

IPO

January 28, 2015

Indexes

Not included

Website

http://ascendispharma.com

Employees

1017

Key Details

Price

$153.92(-1.02%)

Market cap

$9.25B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$393.59M(+36.31% YoY)

Annual EPS

-$7.07(+23.64% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$153.92
ASND price is $153.92

30-Day Relative Volume

0.51
ASND 30-day relative volume is 0.51

Price Performance

Price Most recent change

-1.02%
ASND price was down -1.02% on Apr 15, 2025

Price YTD change

+11.8%
ASND price is up +11.8% since January 1st

Price 1-year change

+5.98%
ASND price is up +5.98% year-on-year

Price 3-year change

+36.39%
ASND price is up +36.39% over the past 3 years

Price Range

Price All-time high

$183.98
ASND price is currently -16.34% below its historical high of $183.98

Price 3-year low

$61.58
ASND price is currently +149.96% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.25B
ASND market capitalization is $9.25 billion

Market cap 3-year change

+46.95%
ASND market capitalization is up +46.95% over the past 3 years

Market cap All-time high

$10.19B
ASND market capitalization is currently -9.22% below its historical high of $10.19 billion

Market cap sector rank

92.19%
ASND market capitalization is higher than 92.19% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.2%
ASND shares outstanding is up +6.2% year-on-year

Shares Outstanding 3-Year Change

+7.74%
ASND shares outstanding is up +7.74% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.52
ASND beta is 0.52

200-day SMA

$136.90
ASND price is currently +12.43% above its 200-day simple moving average

50-day SMA

$148.56
ASND price is currently +3.61% above its 50-day simple moving average

RSI

53.79
ASND 14-day relative strength index is 53.79

Volume

0.51
ASND 30-day relative volume is 0.51

ATR

$9.08
ASND average true range is $9.08

10-day Historical Volatility

49.47%
ASND 10-day historical volatility is 49.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$393.59M
ASND annual revenue is $393.59 million

Revenue Analysts estimate

$575.49M
ASND annual revenue is currently -31.61% lower than the consensus analysts' forecast

Revenue 1-year change

+36.31%
ASND annual revenue is up +36.31% year-on-year

Revenue Sector rank

71.73%
ASND annual revenue is higher than 71.73% of companies in Healthcare sector

EPS

EPS

-$7.07
ASND annual earnings per share is -$7.07

EPS Analysts estimate

-$3.28
ASND annual earnings per share is currently +115.34% higher than the consensus analysts' forecast

EPS 1-year change

+23.64%
ASND annual earnings per share is up +23.64% year-on-year

EPS Sector rank

14.75%
ASND annual earnings per share is higher than 14.75% of companies in Healthcare sector

Profit

Gross profit

$345.68M
ASND annual gross profit is $345.68 million

Gross margin

87.83%
ASND annual gross profit margin is 87.83%

Operating profit

-$301.72M
ASND annual operating income is -$301.72 million

Operating margin

-76.66%
ASND annual operating profit margin is -76.66%

Net income

-$409.22M
ASND annual net profit is -$409.22 million

Net margin

-103.97%
ASND annual net profit margin is -103.97%

Expenses

Total expenses

$695.31M
ASND annual total expenses is $695.31 million

Operating expenses

$647.40M
ASND annual total operating expenses is $647.40 million

Cost of goods sold

$47.90M
ASND annual cost of goods sold is $47.90 million

Selling, general & administrative expenses

$307.98M
ASND annual SGA is $307.98 million

Depreciation and amortization

$19.17M
ASND annual depreciation & amortization is $19.17 million

Interest expense

$70.90M
ASND annual interest expense is $70.90 million

Income tax

$5.24M
ASND annual income tax is $5.24 million

EBIT & EBITDA

EBIT

-$333.08M
ASND annual earnings before interest & taxes is -$333.08 million

EBITDA

-$313.91M
ASND annual EBITDA is -$313.91 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.23B
ASND annual total assets is $1.23 billion

Non current assets

$123.45M
ASND annual long term assets is $123.45 million

Current assets

$1.10B
ASND annual total current assets is $1.10 billion

Cash and cash equivalents

$582.24M
ASND annual cash & cash equivalents is $582.24 million

Accounts receivable

$173.03M
ASND annual accounts receivable is $173.03 million

Inventory

$307.60M
ASND annual inventory is $307.60 million

Liabilities

Total liabilities

$1.34B
ASND annual total liabilities is $1.34 billion

Long term liabilities

$392.65M
ASND annual total long term liabilities is $392.65 million

Current liabilities

$944.70M
ASND annual total current liabilities is $944.70 million

Accounts payable

$100.30M
ASND annual accounts payable is $100.30 million

Debt

Total debt

$891.37M
ASND annual total debt is $891.37 million

Total debt 1-year change

+25.16%
ASND annual total debt is up +25.16% year-on-year

Long term debt

$379.89M
ASND annual long term debt is $379.89 million

Short term debt

$511.48M
ASND annual short term debt is $511.48 million

Equity & Capital

Shareholders equity

-$109.99M
ASND annual stockholders equity is -$109.99 million

Book value

-$109.99M
ASND annual book value is -$109.99 million

Retained earnings

-
ASND annual retained earnings value is unknown

Working capital

$159.21M
ASND annual working capital is $159.21 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$331.41M
ASND annual cash flow from operations is -$331.41 million

Cash from operations 1-year change

+34.5%
ASND annual cash flow from operations is up +34.5% year-on-year

Cash from investing

$7.44M
ASND annual cash flow from investing activities is $7.44 million

Cash from investing 1-year change

-97.6%
ASND annual cash flow from investing activities is down -97.6% year-on-year

Cash from financing

$480.49M
ASND annual cash flow from financing activities is $480.49 million

Cash from financing 1-year change

+230.49%
ASND annual cash flow from financing activities is up +230.49% year-on-year

CAPEX

CAPEX

$1.54M
ASND annual capital expenditures is $1.54 million

CAPEX 1-year change

-41.58%
ASND annual capital expenditures is down -41.58% year-on-year

Free Cash Flow

Free cash flow

-$332.96M
ASND annual free cash flow is -$332.96 million

Free cash flow 1-year change

+34.54%
ASND annual free cash flow is up +34.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

87.83%
ASND annual gross profit margin is 87.83%

Operating margin

-76.66%
ASND annual operating profit margin is -76.66%

Net margin

-103.97%
ASND annual net profit margin is -103.97%

ROA & ROE

ROA

-38.25%
ASND annual return on assets is -38.25%

ROE

372.04%
ASND annual return on equity is 372.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ASND price to earnings ratio value is unknown

PE ratio Sector rank

-
ASND price to earnings ratio is unknown

PB Ratio

PB ratio

-84.14
ASND price to book ratio is -84.14

PB ratio Sector rank

0.33%
ASND price to book ratio is higher than 0.33% of companies in Healthcare sector

PS Ratio

PS ratio

23.61
ASND price to sales ratio is 23.61

PS ratio Sector rank

87.69%
ASND price to sales ratio is higher than 87.69% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.56B
ASND enterprise value is $9.56 billion

Enterprise value Sector rank

91.65%
ASND enterprise value is higher than 91.65% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-35.96
ASND EV/EBITDA is -35.96

EV/EBITDA Sector rank

3.74%
ASND EV/EBITDA is higher than 3.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.17
ASND annual current ratio is 1.17

Quick ratio

0.84
ASND annual quick ratio is 0.84

Leverage

Debt to equity

-8.10
ASND annual debt to equity ratio is -8.10

Interest coverage ratio

-4.70
ASND annual interest coverage ratio is -4.70

Risk & Stability

Piotroski F-Score

4
ASND piotroski f-score is 4

Altman Z-Score

-
ASND altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 18, 25 JP Morgan
Overweight
Feb 25, 25 Cantor Fitzgerald
Overweight
Feb 18, 25 Evercore ISI Group
Outperform
Feb 13, 25 JP Morgan
Overweight
Feb 13, 25 Goldman Sachs
Buy
Feb 11, 25 Cantor Fitzgerald
Overweight
Jan 29, 25 JP Morgan
Overweight
Jan 7, 25 UBS
Buy
Nov 15, 24 Wedbush
Outperform
Nov 15, 24 TD Cowen
Buy

Institutional Ownership

Similar stocks

MEDP logo
Medpace Holdings (MEDP)
WBA logo
Walgreens Boots Alliance (WBA)
QGEN logo
Qiagen NV (QGEN)
ATR logo
AptarGroup (ATR)
VTRS logo
Viatris (VTRS)
NBIX logo
Neurocrine Biosciences (NBIX)
CHE logo
Chemed (CHE)
GMED logo
Globus Medical (GMED)
DOCS logo
Doximity (DOCS)
  • What is the ticker symbol for Ascendis Pharma A/S?
  • Does Ascendis Pharma A/S pay dividends?
  • What sector is Ascendis Pharma A/S in?
  • What industry is Ascendis Pharma A/S in?
  • What country is Ascendis Pharma A/S based in?
  • When did Ascendis Pharma A/S go public?
  • Is Ascendis Pharma A/S in the S&P 500?
  • Is Ascendis Pharma A/S in the NASDAQ 100?
  • Is Ascendis Pharma A/S in the Dow Jones?
  • When was Ascendis Pharma A/S's last earnings report?
  • When does Ascendis Pharma A/S report earnings?

What is the ticker symbol for Ascendis Pharma A/S?

The ticker symbol for Ascendis Pharma A/S is NASDAQ:ASND

Does Ascendis Pharma A/S pay dividends?

No, Ascendis Pharma A/S does not pay dividends

What sector is Ascendis Pharma A/S in?

Ascendis Pharma A/S is in the Healthcare sector

What industry is Ascendis Pharma A/S in?

Ascendis Pharma A/S is in the Biotechnology industry

What country is Ascendis Pharma A/S based in?

Ascendis Pharma A/S is headquartered in Denmark

When did Ascendis Pharma A/S go public?

Ascendis Pharma A/S's initial public offering (IPO) was on January 28, 2015

Is Ascendis Pharma A/S in the S&P 500?

No, Ascendis Pharma A/S is not included in the S&P 500 index

Is Ascendis Pharma A/S in the NASDAQ 100?

No, Ascendis Pharma A/S is not included in the NASDAQ 100 index

Is Ascendis Pharma A/S in the Dow Jones?

No, Ascendis Pharma A/S is not included in the Dow Jones index

When was Ascendis Pharma A/S's last earnings report?

Ascendis Pharma A/S's most recent earnings report was on Feb 12, 2025

When does Ascendis Pharma A/S report earnings?

The next expected earnings date for Ascendis Pharma A/S is May 2, 2025
On this page